INS and Obesity: KEGG pathway enrichment of DALs indicated that the anti-obesity mechanism of WMSZY may involve lipid and atherosclerosis pathways, cholesterol metabolism, regulation of adipocyte lipolysis, fat digestion and absorption, insulin resistance, and glycerolipid metabolism (Figure 4G).